2021-11-18 · Notice · 2021-25111
Discovery Therapeutics, LLC, et al.; Withdrawal of Approval of 18 Abbreviated New Drug Applications
Daptomycin + Eptifibatide
Open attributed record →Federal Register publication year
9 documents attributed to FDA and HHS and published in 2021, connected only through exact reviewed peptide-name matches.
2021-11-18 · Notice · 2021-25111
Daptomycin + Eptifibatide
Open attributed record →2021-11-09 · Notice · 2021-24431
Glucagon + Leuprolide
Open attributed record →2021-11-04 · Notice · 2021-24074
Afamelanotide
Open attributed record →2021-09-02 · Notice · 2021-18928
Exenatide
Open attributed record →2021-08-23 · Notice · 2021-18072
Leuprolide + Semaglutide
Open attributed record →2021-07-28 · Notice · 2021-16047
Eptifibatide
Open attributed record →2021-06-02 · Notice · 2021-11575
Octreotide
Open attributed record →2021-03-25 · Notice · 2021-06202
Bremelanotide + Octreotide
Open attributed record →2021-01-08 · Notice · 2021-00118
Nesiritide
Open attributed record →